심전도 텔레메트리 기기 : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the ECG telemetry devices market size was valued at USD 6.55 billion in 2025 and estimated to grow from USD 6.96 billion in 2026 to reach USD 9.44 billion by 2031, at a CAGR of 6.29% during the forecast period (2026-2031).

This report is Segmented by Product Type (Holter Monitors, Mobile Cardiac Telemetry, Implantable Loop Recorders, and More), Lead Type (Single-Lead, 3-6 Lead, and More), End User (Hospitals & Clinics, Diagnostic Centres, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global ECG Telemetry Devices Market Trends and Insights

Growing CVD Prevalence & Aging Population

Global cardiovascular disease continues rising, and older adults now seek longer monitoring periods that standard 24-48 hour studies cannot fulfill. Continuous telemetry detects more arrhythmias, as evidenced by iRhythm's real-world data showing superior identification rates over Holter modalities Health systems connect the technology to value-based care goals by reducing readmissions and enabling early intervention. Medicare and many private payers broadened coverage, and Rural Health Clinics gained RPM billing eligibility in 2025, further stabilizing demand.

Shift Toward Home & Remote Patient Monitoring

Telehealth adoption matured beyond the pandemic surge once enhanced CPT codes (99453-99458) took effect in 2025, providing predictable reimbursement for ECG telemetry services. Clinical trials link remote ECG oversight to lower 30-day readmissions and faster intervention compared with in-clinic follow-up, strengthening physicians' preference for continuous, real-time insight. IoMT architectures now route encrypted data directly into decision-support dashboards, lowering administrative overhead and speeding triage.

High Device & Data-Service Costs

Procurement budgets face pressure from tariff-driven component inflation, with proposed duties affecting roughly 75% of ECG hardware imported into the United States. Fragmented reimbursement in emerging economies further constrains adoption, as payers seldom cover long monitoring durations. Supply chain bottlenecks and chip shortages elevate BOM costs, squeezing margins for both OEMs and service providers. Smaller hospitals delay replacement cycles or opt for refurbished units, dampening near-term revenue until pricing normalizes or local production scales.

Other drivers and restraints analyzed in the detailed report include:

1. Miniaturization & Wearable-Patch Innovations
2. AI-Enabled Arrhythmia Analytics Adoption
3. Cybersecurity & Data-Privacy Compliance Burden

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

The ECG telemetry devices market size for Holter monitors stood at USD 2.24 billion in 2025, equating to 34.21% of total revenue. Mobile telemetry, while smaller, is projected to deliver the highest 6.65% CAGR, reflecting clinician demand for real-time alerts and patient-friendly wearables. Hospitals still rely on Holters for reimbursed diagnostics, but shifting preference toward automated cloud analytics accelerates mobile uptake. Implantable loop recorders serve niche long-term cases, whereas ECG management platforms facilitate data harmonization across device fleets. Competitive intensity escalates as AliveCor, HeartBeam, and Icentia secure successive FDA clearances between 2024 and 2025, underscoring the expanding innovation pipeline .

Manufacturers embed AI across every product tier, transitioning analytics from differentiator to baseline expectation. Service-oriented models bundle hardware, cloud dashboards, and clinical interpretation, solidifying recurring revenue streams. Consolidation, evidenced by Boston Scientific's Cortex AFib buyout and PaceMate's acquisition of Paceart Optima, aims to assemble end-to-end cardiac care portfolios. Holter incumbency thus faces dual pressure from mobile telemetry's growth and platform-centric competitors re-defining value beyond raw hardware.

Complete Report Scope:

• By Product Type (Value)
  • Holter Monitors
  • Mobile Cardiac Telemetry
  • Implantable Loop Recorders
  • ECG Management Systems
  • Other ECG Telemetry Devices
• By Lead Type (Value)
  • Single-lead
  • 3-6 lead
  • 12-lead
  • Other Leads
• By End User (Value)
  • Hospitals & Clinics
  • Diagnostic Centres
  • Home Healthcare
  • Ambulatory Surgical Centres
  • Others
• By Geography (Value)
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa

Geography Analysis

North America contributed 43.67% of 2025 global revenue, anchored by robust Medicare and private-insurance coverage for RPM services. Enhanced 2025 CPT codes improve rural access and incentivize longer monitoring episodes, sustaining steady upgrades across provider networks. Academic medical centers also spearhead AI validation studies, reinforcing clinical confidence in advanced analytics.

Asia-Pacific records the highest 7.05% CAGR through 2031 as China invests heavily in cardiac care infrastructure and local manufacturing; India benefits from GE Healthcare's expanded plant capacity; and Japan approves iRhythm's platform, showcasing receptive regulatory climates. Rising disposable income and heightened public health campaigns further widen adoption among middle-income groups.

Europe grows consistently as MDR compliance harmonizes quality standards and GDPR aligns with U.S. security mandates, enabling smoother multi-region launches. Partnerships such as Cardiomatics-Biotronik illustrate collaborative momentum around AI software. South America and the Middle East & Africa trail yet present long-term upside once reimbursement and distribution hurdles subside, with Brazil and GCC countries leading early procurement programs.

1. AliveCor
2. Baxter International Inc. (Welch Allyn)
3. Biotricity Inc.
4. Boston Scientific Corp. (Preventice)
5. BPL
6. Cardiac Insight Inc.
7. CompuMed
8. Fukuda Denshi Co. Ltd.
9. GE HealthCare Technologies Inc.
10. iRhythm Technologies
11. Koninklijke Philips
12. Medtronic
13. Mindray Bio-Medical Electronics Co. Ltd.
14. Nihon Kohden Corp.
15. OSI Systems Inc. (Spacelabs Healthcare)
16. Schiller
17. ScottCare Corporation
18. VitalConnect Inc.
19. ZOLL Medical Corp.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing CVD prevalence & aging population
  • 4.2.2 Shift toward home & remote patient monitoring
  • 4.2.3 Miniaturisation & wearable-patch innovations
  • 4.2.4 Reimbursement expansions for RPM services
  • 4.2.5 AI-enabled arrhythmia analytics adoption (under-reported)
  • 4.2.6 Near-shoring of electronics supply chains post-tariff hikes (under-reported)
• 4.3 Market Restraints
  • 4.3.1 High device & data-service costs
  • 4.3.2 Fragmented global reimbursement in emerging markets
  • 4.3.3 Cyber-security & data-privacy compliance burden (under-reported)
  • 4.3.4 Chip-supply volatility affecting production lead-times (under-reported)
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 Market Size & Growth Forecasts

• 5.1 By Product Type (Value)
  • 5.1.1 Holter Monitors
  • 5.1.2 Mobile Cardiac Telemetry
  • 5.1.3 Implantable Loop Recorders
  • 5.1.4 ECG Management Systems
  • 5.1.5 Other ECG Telemetry Devices
• 5.2 By Lead Type (Value)
  • 5.2.1 Single-lead
  • 5.2.2 3-6 lead
  • 5.2.3 12-lead
  • 5.2.4 Other Leads
• 5.3 By End User (Value)
  • 5.3.1 Hospitals & Clinics
  • 5.3.2 Diagnostic Centres
  • 5.3.3 Home Healthcare
  • 5.3.4 Ambulatory Surgical Centres
  • 5.3.5 Others
• 5.4 By Geography (Value)
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 South America
    • 5.4.4.1 Brazil
    • 5.4.4.2 Argentina
    • 5.4.4.3 Rest of South America
  • 5.4.5 Middle East and Africa
    • 5.4.5.1 GCC
    • 5.4.5.2 South Africa
    • 5.4.5.3 Rest of Middle East and Africa

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
  • 6.3.1 AliveCor Inc.
  • 6.3.2 Baxter International Inc. (Welch Allyn)
  • 6.3.3 Biotricity Inc.
  • 6.3.4 Boston Scientific Corp. (Preventice)
  • 6.3.5 BPL Medical Technologies
  • 6.3.6 Cardiac Insight Inc.
  • 6.3.7 CompuMed Inc.
  • 6.3.8 Fukuda Denshi Co. Ltd.
  • 6.3.9 GE HealthCare Technologies Inc.
  • 6.3.10 iRhythm Technologies Inc.
  • 6.3.11 Koninklijke Philips N.V.
  • 6.3.12 Medtronic plc
  • 6.3.13 Mindray Bio-Medical Electronics Co. Ltd.
  • 6.3.14 Nihon Kohden Corp.
  • 6.3.15 OSI Systems Inc. (Spacelabs Healthcare)
  • 6.3.16 Schiller AG
  • 6.3.17 ScottCare Corporation
  • 6.3.18 VitalConnect Inc.
  • 6.3.19 ZOLL Medical Corp.

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment